India Struggles to Make Advanced Cancer Treatment Accessible

India remains behind other countries when it comes to offering affordable CAR T-cell therapy although this treatment uses modified immune cells to fight cancer effectively. In 2017 the United States permitted CAR T-cell therapy yet both China approved their version in 2021 and India has no domestic production of this vital cancer treatment as of now.

Doctors use CAR T-cell therapy to change immune cells so they hunt for cancer cells the body usually misses. Healthcare specialists collect patient T-cells and then alter them to use them against cancer at the body’s target sites. Customized cancer therapy works well against blood diseases but India has no way to make it affordable because the country needs local production facilities.

The imported therapy costs from 3 million to 4 million rupees which makes it affordable only to a small group of patients in India. Medical professionals support creating research labs and quality standards to produce this treatment at home which may deliver 60-70% savings. Many Indian patients with cancer still need to wait because this advanced therapy remains expensive enough that they cannot use it.

A Khan

Recent Posts

STI’s Sudden Slowdown: What Singapore’s Market Pullback Reveals About Global Risk Mood

A​‍​‌‍​‍‌​‍​‌‍​‍‌ Market Catching Its Breath The Singapore market turned noticeably quieter after the Straits Times Index (STI) went down, reflecting…

December 6, 2025

Waves of Power: Decoding China’s Bold Fleet Deployment Across East Asian Seas

In​‍​‌‍​‍‌​‍​‌‍​‍‌ response to a sudden and highly visible spike in strategic naval operations, the attention of the world has been…

December 5, 2025

Rising Regional Tensions: How Naval Build-Up Near Taiwan and Japan Is Reshaping East Asian Security

The fast naval build-up in the area of Taiwan and Japan is causing the tension of East Asia to be…

December 5, 2025

Shifting Investment Tides: Asia’s IPO Boom and the AI-Bubble Warning for 2026

The future of Asia in 2026 has an excellent combination of both opportunities and risks: a fresh wave of IPO…

December 5, 2025

When Hunger Has a Gender: Unpacking the Global Food Access Gap Women Face

On​‍​‌‍​‍‌​‍​‌‍​‍‌ a dining table, food from many different cultures may look the same, but that is not the case. After…

December 5, 2025

Asia Power Index 2025: Unmasking the Power Shifts in a US–China Dominated Region — And India’s Strategic Rise

Asia​‍​‌‍​‍‌​‍​‌‍​‍‌ Power Index 2025 reveals a significant change of the region of Asia, transforming the entire continent. While the struggle…

December 5, 2025

This website uses cookies.

Read More